Age differences in associations of serum alkaline phosphatase and mortality among peritoneal dialysis patients  

作　　者：Juan Wu Xin-Hui Liu Rong Huang Hai-Shan Wu Qun-Ying GUO Chun-Yan Yi Xue-Qing YU Xiao Yang 

机构地区：[1]Department of Nephrology,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou,Guangdong 510080,China [2]Key Laboratory of Nephrology,Nationa[Health Commission and Guangdong Province,Guangzhou,Guangdong 510080,China [3]Department of Nephrology,Zhejiang Provincial People's Hospital,Hangzhou,Zhejiang 310014,China

出　　处：《Chinese Medical Journal》2019年第2期232-236,共5页中华医学杂志（英文版）

基　　金：grants from the Natural Science Foundation of China (Nos.81774069,81570614, 81600.516,81603437);National Key Research and Development Program (No.2016YFC0906101);Program of the Ministry of Health of China (No.201502023), the Guangdong Science Foundation of China (Nos. 2014B020212020,2017A050503003,2017B020227006);Foundation of Guangdong Key Laboratory of Nephrology (No.2017B030314019);the Guangzhou Committee of Science and Technology,China (No.201704020167);and the Medical and Health Program of Zhejiang Province, China (No.2016KYB018).

摘　　要：To the Editor:Serum alkaline phosphatase (ALP) is an important bone turnover marker in chronic kidney disease (CKD) patients, with studies indicating that higher serum ALP levels are associated with increased mortality in hemodialysis (HD) patients.[1] Our previous study also showed that higher serum ALP levels were independently associated with all-cause and cardiovascular mortality in peritoneal dialysis (PD) patients.

关 键 词：Serum ALKALINE PHOSPHATASE TURNOVER chronic KIDNEY 

分 类 号：R[医药卫生]